545 active trials 316 recruiting 45 Phase 3 305 sponsors 66 changes in 30 days
| Early Phase 1 | 42 | |
| Phase 1 | 114 | |
| Phase 1/2 | 48 | |
| Phase 2 | 64 | |
| Phase 2/3 | 4 | |
| Phase 3 | 41 | |
| Phase 4 | 19 |
| NCT ID | Title | Sponsor | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06594068 | Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in… | AstraZeneca | Recruiting | 2026-08-18 |
| NCT07760480 | Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months… | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Recruiting | 2026-08-12 |
| NCT07611214 | PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients… | Aurinia Pharmaceuticals Inc. | Recruiting | 2026-08-03 |
| NCT07719140 | Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT… | Peking Union Medical College Hospital | Recruiting | 2026-07-22 |
| NCT07087912 | Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in… | University of Sao Paulo General Hospital | Recruiting | 2026-07-20 |
| NCT07700940 | The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population | Ahmed Yehia Ismail | Recruiting | 2026-07-15 |
| NCT03543839 | Trial of Belimumab in Early Lupus | Northwell Health | Recruiting | 2026-06-12 |
| NCT06411249 | A Study Describing the Efficacy and Safety of Belimumab Administered in Adult… | GlaxoSmithKline | Recruiting | 2026-06-03 |
| NCT07611747 | Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in… | Instituto de Investigación Marqués de Valdecilla | Recruiting | 2026-05-28 |
| NCT07323524 | Dapagliflozin in Active Lupus Nephritis | Brigham and Women's Hospital | Recruiting | 2026-05-26 |
| NCT06875960 | A Study to Continue the Administration of Deucravacitinib in Participants With Systemic… | Bristol-Myers Squibb | Recruiting | 2026-03-30 |
| NCT07077486 | Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease | Tongji Hospital | Recruiting | 2026-01-27 |
| NCT05559671 | Safety of the Herpes Zoster Subunit Vaccine in Lupus | NYU Langone Health | Recruiting | 2025-12-26 |
| NCT07225387 | Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of… | NephroNet, Inc. | Recruiting | 2025-11-06 |
| NCT05207358 | Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis | Institutul Clinic Fundeni | Recruiting | 2022-03-03 |
| NCT07381465 | Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus | Chinese SLE Treatment And Research Group | Active, Not Recruiting | 2026-07-15 |
| NCT05879419 | Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases | University of Sao Paulo General Hospital | Active, Not Recruiting | 2026-05-04 |
| NCT07035834 | SGLT-2 Inhibitors on Albuminuria in Chronic Kidney Disease Patients With Lupus Nephritis… | Federico II University | Not Yet Recruiting | 2025-06-25 |
| NCT06677801 | Immune Cell Subsets in SLE Patients Treated with Telitacicept | Second Affiliated Hospital, School of Medicine, Zhejiang University | Active, Not Recruiting | 2024-11-07 |
| Phase 3 | ||||
| NCT06711887 | Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study… | Novartis Pharmaceuticals | Recruiting | 2026-08-24 |
| NCT06617325 | A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants… | UCB Biopharma SRL | Recruiting | 2026-08-21 |
| NCT05799378 | Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease | NYU Langone Health | Recruiting | 2026-08-20 |
| NCT07430306 | A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in… | AstraZeneca | Recruiting | 2026-08-20 |
| NCT07355218 | A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or… | EMD Serono Research & Development Institute, Inc. | Recruiting | 2026-08-17 |
| NCT07332481 | A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or… | EMD Serono Research & Development Institute, Inc. | Recruiting | 2026-08-14 |
Assiut University (25) · AstraZeneca (25) · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (13) · The Children's Hospital of Zhejiang University School of Medicine (11) · Novartis Pharmaceuticals (10) · Sohag University (8) · Assistance Publique - Hôpitaux de Paris (7) · China Immunotech (Beijing) Biotechnology Co., Ltd. (7) · Tongji Hospital (7) · Beijing GoBroad Hospital (6)